Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

Delayed Quote. Delayed  - 05/31 09:59:59 pm
2.96 USD   +3.86%
05/06 GERON : reports 1Q loss
05/05 Geron Corporation Reports First Quarter 2016 Financial Results an..
04/27 Geron Announces Conference Call to Discuss First Quarter 2016 Fin..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/24/2016 05/25/2016 05/26/2016 05/27/2016 05/31/2016 Date
2.92(c) 2.94(c) 2.81(c) 2.85(c) 2.96 Last
1 628 859 2 207 916 2 184 549 1 073 420 2 371 312 Volume
+2.82% +0.68% -4.42% +1.42% +3.86% Change
More quotes
Financials ($)
Sales 2016 1,65 M
EBIT 2016 -42,0 M
Net income 2016 -39,1 M
Debt 2016 -
Yield 2016 -
Sales 2017 48,1 M
EBIT 2017 2,51 M
Net income 2017 3,18 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 275x
Capi. / Sales 2017 9,41x
Capitalization 453 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park,... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
05/06 GERON : reports 1Q loss
05/05 Geron Corporation Reports First Quarter 2016 Financial Results and Recent Eve..
04/27 Geron Announces Conference Call to Discuss First Quarter 2016 Financial Resul..
04/20 Geron Announces Two Imetelstat Poster Presentations at the American Associati..
04/06 GERON : to Present at the Needham Healthcare Conference
04/05 Geron to Present at the Needham Healthcare Conference
03/30 GERON CORPORATION : Why Investors Are So Bullish on This Small Biotech
03/17 Geron Announces Presentations at American Association of Cancer Research Annu..
03/02 GERON CORPORATION : (NASDAQ: GERN) Favorable Financial Results and Positive Guid..
02/26 GERON : reports 4Q loss
More news
Sector news : Bio Therapeutic Drugs
05/31 INCYTE : Announces the Launch of the Incyte Charitable Giving Foundation
05/31 QIAGEN NV : Integrates Quality Control Tools into GeneReader NGS System
05/31 VERTEX PHARMACEUTICALS : to Present at the Goldman Sachs Healthcare Conference o..
05/31 ALNYLAM PHARMACEUTICALS : to Webcast Presentations at Upcoming June Investor Con..
05/31 GENMAB A/S : Total Number of Voting Rights and Total Share Capital
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/31 A Milestone Event In Geron's Imetelstat Phase II Study For Myelofibrosis Pati..
05/05 Geron's (GERN) CEO John Scarlett on Q1 2016 Results - Earnings Call Transcrip..
05/05 Geron EPS in-line, beats on revenue
05/04 Notable earnings after Thursday?s close
03/21 An Analysis Of The iShares Micro-Cap ETF
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions